Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Cabozantinib With Selumetinib for Plexiform NeurofibromasCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibromaRecruitingPhase 12026-10-02NCT06502171

4 results · Page 1 of 1

Swipe the table sideways for more columns.

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Boston Children's HospitalBostonUnited States343
Children's Hospital of Los AngelesLos AngelesUnited States56
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Children's National HospitalWashington D.C.United States100
Childrens of AlabamaBirminghamUnited States2
Cincinnati Children's Hospital Medical CenterCincinnatiUnited States21
Riley Hospital for Children/Indiana UniversityIndianapolisUnited States2
University of Texas, SouthwesternDallasUnited States5